JNJ: Johnson & Johnson Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 398,364.39
Enterprise Value ($M) 423,896.39
Book Value ($M) 74,599.00
Book Value / Share 28.54
Price / Book 5.34
NCAV ($M) -55,280.00
NCAV / Share -21.15
Price / NCAV -7.21

Profitability (mra)
Return on Invested Capital (ROIC) 0.16
Return on Assets (ROA) 0.10
Return on Equity (ROE) 0.26

Liquidity (mrq)
Quick Ratio 0.77
Current Ratio 0.99

Balance Sheet (mrq) ($M)
Current Assets 55,294.00
Assets 187,378.00
Liabilities 110,574.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 94,943.00
Operating Income 25,673.00
Net Income 17,941.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 21,194.00
Cash from Investing -12,371.00
Cash from Financing -8,871.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-10 13G/A State Street Corp 5.45 -1.76
02-09 13G/A Vanguard Group Inc 9.44 5.13
01-31 13G/A BlackRock Inc. 7.60 -0.61

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-02-16 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 1, 2023 or ☐ Transition Report Pursuant to Section 13 or
2022-10-27 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2022-07-29 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2022-04-29 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2023-03-17 1,129,586 8,919,373 12.66
2023-03-16 520,580 5,596,404 9.30
2023-03-15 447,674 5,132,769 8.72
2023-03-14 584,632 5,420,836 10.78

(click for more detail)

Similar Companies
GSK – GlaxoSmithKline plc JATT – JATT Acquisition Corp – Class A
JATT.U – JATT Acquisition Corp Units, each consisting of one Class A ordinary share, and one-half of one rede LCI – Lannett Company, Inc.
LLY – Eli Lilly And Co


Financial data and stock pages provided by
Fintel.io


Finpedia: Johnson & Johnson